We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Nivolumab (OPDIVO®)  [Polish]

Nivolumab (OPDIVO®) [Polish] (January 2020)

Nivolumab (OPDIVO®) is a targeted therapy drug used to treat melanoma, non-small cell lung cancer or kidney (renal cell) cancer. 

Author(s)
Macmillan Cancer Support
Place of publication
London
Date of publication
January 2020
Pages
12pp
Price
Free.
Format
Factsheet
Language
Polish
Download this resource
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm